IRCT201612077732N2已完成1 期
Vitamin D supplementation for the treatment of non alcoholic fatty liver disease: a randomized double blind placebo controlled trial
Vice Chancellor for Research, Shiraz University of Medical Sciences0 个研究点目标入组 106 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 106
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 75 years（—）
- 性别
- All
入选标准
- •men and women aged between 20 and 75 years
- •with presence of hepatic steatosis diagnosed by ultrasound (US)
- •Exclusion criteria: Patients with liver cirrhosis; patients with hepatitis B or hepatitis C; patients with alcohol consumption (> 10 gr/ day); patients with autoimmune hepatitis; Wilson’s disease and hemochromatosis; known cancer; nephrolithiasis; nephrocalcinosis; chronic renal failure; hypercalcemia; hypercalciurea; pregnancy; lactation; patients receiving estrogen; tamoxifen; methotrexate; amiodarone; tetracycline and those receiving vitamin D and calcium supplementations in previous 6 months.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Benefit of Vitamin D supplementation in treatment of Polycystic ovary syndrome (PCOS)CTRI/2018/02/012104Intramural
招募中
3 期
A clinical trial to study the effect of Vitamin D in patients of systemic lupus erythematosus.CTRI/2017/07/009033Bidyut Kumar Das
已完成
不适用
Effect of Vitamin D supplementation in treatment of First episode PsychosisCTRI/2017/07/009136Central Institute of Psychiatry60
尚未招募
3 期
To Study the Role of Vitamin D in the Treatment of Confirmed COVID-19 InfectioCTRI/2020/12/030083Pulse Pharmaceuticals Pvt Ltd
招募中
3 期
Study the effect of vitamin D on nasal polypsOther polyp of sinussinunasal polyposis.IRCT20180217038763N1Mashhad University of Medical Sciences60